Diet composition exacerbates or attenuates soman toxicity in rats: Implied metabolic control of nerve agent toxicity

NeuroToxicology

Volumn 32, Issue 3, 2011, Pages 342-349

  Myers, Todd M ^a   Langston, Jeffrey L ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Active avoidance behavior; Diet composition; Organophosphorus nerve agent; Rat; Soman; Survival

Indexed keywords

ACETYLCHOLINE; SOMAN; SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CHOLINE DIET; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOOD COMPOSITION; GLUCOSE INTAKE; GROWTH RATE; KETOGENIC DIET; LD 50; MALE; METABOLIC REGULATION; MORTALITY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE; TOXIN ANALYSIS; WEIGHT REDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BODY WEIGHT; CHEMICAL WARFARE AGENTS; CHOLINE; DIET; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; GLUCOSE; KETOGENIC DIET; LETHAL DOSE 50; MALE; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; SOMAN; TIME FACTORS;

RATTUS; RODENTIA;

EID: 79953236442     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2011.03.001     Document Type: Article

References (76)

1. Agarwal V.R., Rastogi A.K., Sahib M.K., Sagar P. In vitro insulin effect on acetylcholine esterase of erythrocyte membranes of normal and diabetic rats. Acta Diabetol Lat 1985, 22:359-363.
2. Aoyagi T., Wada T., Kojima F., Nagai M., Akanuma Y., Akanuma H., et al. Relation of blood glucose levels to the changes in plasma levels of various hydrolytic enzymes in diabetic patients. Biochem Int 1985, 10:821-827.
3. Aracava Y., Pereira E.F., Akkerman M., Adler M., Albuquerque E.X. Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine. J Pharmacol Exp Ther 2009, 331:1014-1024.
4. Bajgar J., Fusek J., Kassa J., Kuca K., Jun D. Chemical aspects of pharmacological prophylaxis against nerve agent poisoning. Curr Med Chem 2009, 16:2977-2986.
5. Bough K.J., Rho J.M. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007, 48:43-58.
6. Bough K.J., Wetherington J., Hassel B., Pare J.F., Gawryluk J.W., Greene J.G., et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol 2006, 60:223-235.
7. Costa L.G., Vitalone A., Cole T.B., Furlong C.E. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005, 69:541-550.
8. Dash N.K., Azam M., Gupta G., Baquer N.Z. Effect of hyperglycemia on acetylcholinesterase and catecholamine levels in rat brain and heart. Biochem Int 1991, 23:261-269.
9. DeVivo D.C., Malas K.L., Leckie M.P. Starvation and seizures. Observation on the electroconvulsive threshold and cerebral metabolism of the starved adult rat. Arch Neurol 1975, 32:755-760.
10. Fenech M. The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Mutagenesis 2005, 20:255-269.
11. Fletcher H.P., Akbar W.J., Peoples R.W., Spratto G.R. Effect of acute soman on selected endocrine parameters and blood glucose in rats. Fundam Appl Toxicol 1988, 11:580-586.
12. Fletcher H.P., Noble S.A., Spratto G.R. Effects of the acetylcholinesterase inhibitor pinacolyl methylphosphonofluoridate (soman) on selected endocrine, glucose, and catecholamine levels in fasted and fed rats. Toxicology 1988, 52:323-329.
13. Fox G.R., Virgo B.B. Relevance of hyperglycemia to dieldrin toxicity in suckling and adult rats. Toxicology 1986, 38:315-326.
14. Gasior M., French A., Joy M.T., Tang R.S., Hartman A.L., Rogawski M.A. The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia 2007, 48:793-800.
15. Greene A.E., Todorova M.T., McGowan R., Seyfried T.N. Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 2001, 42:1371-1378.
16. Greene A.E., Todorova M.T., Seyfried T.N. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J Neurochem 2003, 86:529-537.
17. Guseva M.V., Hopkins D.M., Scheff S.W., Pauly J.R. Dietary choline supplementation improves behavioral, histological, and neurochemical outcomes in a rat model of traumatic brain injury. J Neurotrauma 2008, 25:975-983.
18. Haigh J.R., Johnston S.R., Peppernay A., Mattern P.J., Garcia G.E., Doctor B.P., et al. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase. Chem Biol Interact 2008, 175:380-386.
19. Hartman A.L., Gasior M., Vining E.P., Rogawski M.A. The neuropharmacology of the ketogenic diet. Pediatr Neurol 2007, 36:281-292.
20. Hennig B., Ettinger A.S., Jandacek R.J., Koo S., McClain C., Seifried H., et al. Using nutrition for intervention and prevention against environmental chemical toxicity and associated diseases. Environ Health Perspect 2007, 115:493-495.
21. Holmes G.L., Yang Y., Liu Z., Cermak J.M., Sarkisian M.R., Stafstrom C.E., et al. Seizure-induced memory impairment is reduced by choline supplementation before or after status epilepticus. Epilepsy Res 2002, 48:3-13.
22. Honmura A., Yanase M., Saito H., Iguchi A. Effect of intrahypothalamic injection of neostigmine on the secretion of epinephrine and norepinephrine and on plasma glucose level. Endocrinology 1992, 130:2997-3002.
23. Kant G.J., Shih T.M., Leu J.R., Raslear T.G., Mougey E.H. Long-term sequelae of soman exposure: hormonal rhythms two weeks postexposure to a single dose. Fundam Appl Toxicol 1988, 10:154-163.
24. Kassa J., Karasova J.Z., Tesarova S., Kuca K., Musilek K. A comparison of the ability of newly-developed bispyridinium oxime K203 and currently available oximes (trimedoxime, obidoxime, HI-6) to counteract the acute neurotoxicity of soman in rats. Toxicol Mech Methods 2010, 20:445-451.
25. Keenan K.P., Ballam G.C., Soper K.A., Laroque P., Coleman J.B., Dixit R. Diet, caloric restriction, and the rodent bioassay. Toxicol Sci 1999, 52:24-34.
26. Kopf S.R., Baratti C.M. Effects of posttraining administration of glucose on retention of a habituation response in mice: participation of a central cholinergic mechanism. Neurobiol Learn Mem 1996, 65:253-260.
27. Koppen A., Klein J., Erb C., Loffelholz K. Acetylcholine release and choline availability in rat hippocampus: effects of exogenous choline and nicotinamide. J Pharmacol Exp Ther 1997, 282:1139-1145.
28. Kuca K., Musilek K., Jun D., Pohanka M., Ghosh K.K., Hrabinova M. Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticide-inhibited acetylcholinesterase. J Enzyme Inhib Med Chem 2010, 25:509-512.
29. Kudchodkar B.J., Lacko A.G., Dory L., Fungwe T.V. Dietary fat modulates serum paraoxonase 1 activity in rats. J Nutr 2000, 130:2427-2433.
30. Lallement G., Baille V., Baubichon D., Carpentier P., Collombet J.M., Filliat P., et al. Review of the value of huperzine as pretreatment of organophosphate poisoning. Neurotoxicology 2002, 23:1-5.
31. Lenz D.E., Yeung D., Smith J.R., Sweeney R.E., Lumley L.A., Cerasoli D.M. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicology 2007, 233:31-39.
32. Liu J., Gupta R.C., Goad J.T., Karanth S., Pope C. Modulation of parathion toxicity by glucose feeding: is nitric oxide involved?. Toxicol Appl Pharmacol 2007, 219:106-113.
33. Liu J., Karanth S., Pope C. Dietary modulation of parathion-induced neurotoxicity in adult and juvenile rats. Toxicology 2005, 210:135-145.
34. Maalouf M., Rho J.M., Mattson M.P. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 2009, 59:293-315.
35. Mackness B., Durrington P.N., Boulton A.J., Hine D., Mackness M.I. Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. Eur J Clin Invest 2002, 32:259-264.
36. Mantis J.G., Centeno N.A., Todorova M.T., McGowan R., Seyfried T.N. Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies. Nutr Metab (Lond) 2004, 1:11.
37. Maxwell D.M., Brecht K.M., O'Neill B.L. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol Lett 1987, 39:35-42.
38. McCann J.C., Hudes M., Ames B.N. An overview of evidence for a causal relationship between dietary availability of choline during development and cognitive function in offspring. Neurosci Biobehav Rev 2006, 30:696-712.
39. McDonough J.H., Van Shura K.E., LaMont J.C., McMonagle J.D., Shih T.M. Comparison of the intramuscular, intranasal or sublingual routes of midazolam administration for the control of soman-induced seizures. Basic Clin Pharmacol Toxicol 2009, 104:27-34.
40. Myers T.M., Langston J.L., McDonough J.H. Characterizing the effects of short-term and long-term dietary restriction on the toxicity of soman in male guinea pigs of different ages. Internal report to special projects officer and In-House Laboratory Independent Research (ILIR) committee 2005.
41. Myhrer T., Enger S., Aas P. Anticonvulsant efficacy of drugs with cholinergic and/or glutamatergic antagonism microinfused into area tempestas of rats exposed to soman. Neurochem Res 2008, 33:348-354.
42. Myhrer T., Enger S., Aas P. Modulators of metabotropic glutamate receptors microinfused into perirhinal cortex: anticonvulsant effects in rats challenged with soman. Eur J Pharmacol 2010, 636:82-87.
43. Nold J.B., Keenan K.P., Nyska A., Cartwright M.E. Society of toxicologic pathology position paper: diet as a variable in rodent toxicology and carcinogenicity studies. Toxicol Pathol 2001, 29:585-586.
44. Olivier K., Liu J., Karanth S., Zhang H., Roane D.S., Pope C.N. Glucose feeding exacerbates parathion-induced neurotoxicity. J Toxicol Environ Health A 2001, 63:253-271.
45. Patel B.N., Mackness M.I., Harty D.W., Arrol S., Boot-Handford R.P., Durrington P.N. Serum esterase activities and hyperlipidaemia in the streptozotocin-diabetic rat. Biochim Biophys Acta 1990, 1035:113-116.
46. Patterson T.A., Terry A.V., Kosh J.W. Prevention of physostigmine-DFP-, and diazinon-induced acute toxicity by monoethylcholine and N-aminodeanol. Br J Pharmacol 1989, 97:451-460.
47. Peoples R.W., Spratto G.R., Akbar W.J., Fletcher H.P. Effect of repeated administration of soman on selected endocrine parameters and blood glucose in rats. Fundam Appl Toxicol 1988, 11:587-593.
48. Ragozzino M.E., Unick K.E., Gold P.E. Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose. Proc Natl Acad Sci U S A 1996, 93:4693-4698.
49. Rho J.M., Anderson G.D., Donevan S.D., White H.S. Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 2002, 43:358-361.
50. Rho J.M., Sankar R. The ketogenic diet in a pill: is this possible?. Epilepsia 2008, 49(Suppl. 8):127-133.
51. Saxena A., Sun W., Luo C., Myers T.M., Koplovitz I., Lenz D.E., et al. Bioscavenger for protection from toxicity of organophosphorus compounds. J Mol Neurosci 2006, 30:145-148.
52. Schwartzkroin P.A. Mechanisms underlying the anti-epileptic efficacy of the ketogenic diet. Epilepsy Res 1999, 37:171-180.
53. Schwechter E.M., Veliskova J., Velisek L. Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann Neurol 2003, 53:91-101.
54. Seifert J. Toxicologic significance of the hyperglycemia caused by organophosphorous insecticides. Bull Environ Contam Toxicol 2001, 67:463-469.
55. Shakman R.A. Nutritional influences on the toxicity of environmental pollutants: a review. Arch Environ Health 1974, 28:105-113.
56. Shih T.M., Rowland T.C., McDonough J.H. Anticonvulsants for nerve agent-induced seizures: the influence of the therapeutic dose of atropine. J Pharmacol Exp Ther 2007, 320:154-161.
57. Sidell F.R., Newmark J., McDonough J.H. Nerve agents. Medical aspects of chemical warfare 2008, 155-220. Borden Institute, Washington, DC. S.D. Tuorinsky (Ed.).
58. Slotkin T.A., Lassiter T.L., Ryde I.T., Wrench N., Levin E.D., Seidler F.J. Consumption of a high-fat diet in adulthood ameliorates the effects of neonatal parathion exposure on acetylcholine systems in rat brain regions. Environ Health Perspect 2009, 117:916-922.
59. Sokoloff L. Metabolism of ketone bodies by the brain. Annu Rev Med 1973, 24:271-280.
60. Stafstrom C.E. Animal models of the ketogenic diet: what have we learned, what can we learn?. Epilepsy Res 1999, 37:241-259.
61. Stone W.S., Cottrill K.L., Walker D.L., Gold P.E. Blood glucose and brain function: interactions with CNS cholinergic systems. Behav Neural Biol 1988, 50:325-334.
62. Stone W.S., Croul C.E., Gold P.E. Attenuation of scopolamine-induced amnesia in mice. Psychopharmacology (Berlin) 1988, 96:417-420.
63. Stovner J. The effect of choline on the action of anticholinesterases. Acta Pharmacol Toxicol (Copenh) 1956, 12:175-186.
64. Ueyama J., Wang D., Kondo T., Saito I., Takagi K., Takagi K., et al. Toxicity of diazinon and its metabolites increases in diabetic rats. Toxicol Lett 2007, 170:229-237.
65. Van Lith H.A., Herman S., Zhang X., Van Der Palen J.G., Van Zutphen L.F., Beynen A.C. Influence of dietary fats on butyrylcholinesterase and esterase-1 (ES-1) activity in plasma of rats. Lipids 1990, 25:779-786.
66. Van Lith H.A., Meijer G.W., Van Zutphen L.F., Beynen A.C. Plasma esterase-1 (ES-1) activity is increased in rats fed high-fat diets. Lipids 1989, 24:86-88.
67. Van Lith H.A., Van Zutphen L.F., Beynen A.C. Butyrylcholinesterase activity in plasma of rats and rabbits fed high-fat diets. Comp Biochem Physiol A: Comp Physiol 1991, 98:339-342.
68. Wecker L. Neurochemical effects of choline supplementation. Can J Physiol Pharmacol 1986, 64:329-333.
69. Wecker L., Dettbarn W.D., Schmidt D.E. Choline administration: modification of the central actions of atropine. Science 1978, 199:86-87.
70. Wecker L., Flynn C.J., Stouse M.R., Trommer B.A. Choline availability: effects on the toxicity of centrally active drugs. Drug Nutr Interact 1982, 1:125-130.
71. Wetherell J., Price M., Mumford H., Armstrong S., Scott L. Development of next generation medical countermeasures to nerve agent poisoning. Toxicology 2007, 233:120-127.
72. Yan H., Harding J.J. Inactivation and loss of antigenicity of esterase by sugars and a steroid. Biochim Biophys Acta 1999, 1454:183-190.
73. Yan H., Harding J.J. The molecular chaperone, alpha-crystallin, protects against loss of antigenicity and activity of esterase caused by sugars, sugar phosphate and a steroid. Biol Chem 2003, 384:1185-1194.
74. Yan H., Harding J.J. Carnosine protects against the inactivation of esterase induced by glycation and a steroid. Biochim Biophys Acta 2005, 1741:120-126.
75. Yang Y., Liu Z., Cermak J.M., Tandon P., Sarkisian M.R., Stafstrom C.E., et al. Protective effects of prenatal choline supplementation on seizure-induced memory impairment. J Neurosci 2000, 20:RC109.
76. Ziegler D.R., Araujo E., Rotta L.N., Perry M.L., Goncalves C.A. A ketogenic diet increases protein phosphorylation in brain slices of rats. J Nutr 2002, 132:483-487.